Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Elicera Therapeutics AB

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 51 More Arrow 86 Less Arrow 0
Earnings before taxes -11,014 Less Arrow -12,990 More Arrow -2,053
EBITDA -11,475 Less Arrow -12,931 More Arrow -2,048
Total assets 20,271 More Arrow 30,945 More Arrow 39,802
Current assets 20,262 More Arrow 30,605 More Arrow 39,424
Current liabilities 9,255 Less Arrow 9,027 Less Arrow 1,818
Equity capital 11,016 More Arrow 21,917 More Arrow 37,984
- share capital 558 Less Arrow 555 More Arrow 604
Employees (average) 2 Equal arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 54.3% More Arrow 70.8% More Arrow 95.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -54.1% More Arrow -41.7% More Arrow -5.2%
Current ratio 218.9% More Arrow 339.0% More Arrow 2168.5%
Return on equity (ROE) -100.0% More Arrow -59.3% More Arrow -5.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.